Bunge Global SA
Simply Wall St says Bunge Global (BG) reported Q2 2026 results and raised full-year guidance, citing progress on integrating Viterra and ongoing share repurchases. The stock trades around $108.38, down 13.25% over 90 days but up 16.99% YTD and 34.35% over one year. A “fair value” narrative targets $142 per share, about 24% upside, while noting integration and demand risks.
Investing.com reports Bunge shares rose about 3.7% after its Q2 2026 results (released July 29). Adjusted EPS was $2.00 vs ~$1.95 expected, and revenue was $24.04B vs expectations. The stock had fallen on concerns about Viterra integration and working capital. Analysts at Texas Capital and BMO reiterated Buy, with a $150 target, and an Aug. 18 ex-dividend date for a $0.72 quarterly payment.
Mahoney Christopher purchased 6,500 shares of Bunge Global SA (BG) at an average of $106.01 ($105.53–$107.60, $0.69M total) across 2 trades over 2026-07-31 to 2026-08-04.
Over the past 7 days, alphai's AI scored 2 news stories mentioning BG (Bunge Global SA). Coverage has skewed bullish: 1 bullish, 1 neutral, and 0 bearish.
Recent BG coverage spans earnings, financial news and market movers.
In the last 30 days, BG insiders filed 2 SEC Form 4 transactions — 2 purchases ($689K) and no sales. The most active reporter was Mahoney Christopher with 2 filings.
The article frames BG as potentially undervalued versus a stated fair value, but it does not add verifiable new deal or guidance numbers beyond what is already referenced.
The stock’s rebound is attributed to post-earnings guidance support plus a near-term dividend catalyst and renewed analyst Buy/PT support.
This is a director open-market buy, which can be read as mild positive sentiment but is not a fundamental catalyst by itself.
The article frames improving synergies and processing capacity as margin tailwinds, but flags ongoing merchandising pressure and policy/geopolitical risks.
The approval lowers execution risk for BAWAG’s acquisition of PTSB, supporting deal progression toward completion in Q4 2026 or Q1 2027.
alphai scores every news story that mentions BG with an AI model for sentiment and relevance, and aggregates insider trades from Bunge Global SA's SEC EDGAR Form 4 filings. Figures refresh continuously.
Simply Wall St says Bunge Global (BG) reported Q2 2026 results and raised full-year guidance, citing progress on integrating Viterra and ongoing share repurchases. The stock trades around $108.38, down 13.25% over 90 days but up 16.99% YTD and 34.35% over one year. A “fair value” narrative targets $142 per share, about 24% upside, while noting integration and demand risks.
6 min readInvesting.com reports Bunge shares rose about 3.7% after its Q2 2026 results (released July 29). Adjusted EPS was $2.00 vs ~$1.95 expected, and revenue was $24.04B vs expectations. The stock had fallen on concerns about Viterra integration and working capital. Analysts at Texas Capital and BMO reiterated Buy, with a $150 target, and an Aug. 18 ex-dividend date for a $0.72 quarterly payment.
3 min readMahoney Christopher purchased 6,500 shares of Bunge Global SA (BG) at an average of $106.01 ($105.53–$107.60, $0.69M total) across 2 trades over 2026-07-31 to 2026-08-04.
2 min readBunge Global’s Q2 outlook was discussed, focusing on benefits from the Viterra integration, including expanded origination and processing capacity in Argentina, Canada, and Europe. Management cited improved internal liquidity and synergy tracking ahead of plan, plus capital projects in Louisiana and other sites. The stock was noted at $109.10.
6 min readPermanent TSB (PTSB) shareholders approved BAWAG Group’s all-cash offer to buy 100% of PTSB’s issued share capital. The scheme meeting vote backed the transaction with 91% of votes cast, and related resolutions at the EGM received required approvals. Completion is expected in Q4 2026 or Q1 2027, pending court sanction and remaining regulatory approvals.
3 min readBunge Global SA (BG) raised its 2026 adjusted EPS outlook to $9.25 to $9.75 from $9.00 to $9.50, citing higher Soybean Processing and Refining and Softseed Processing and Refining, and lower Grain Merchandising and Milling. Q2 earnings were $678 million, or $3.47/share, versus $354 million, or $2.61/share a year earlier. Revenue rose 88.3% to $24.041 billion. Shares were up 1.29% pre-market at $118.88.
2 min readBunge Global (NYSE:BG) reported Q2 CY2026 results, with sales rising 88.3% year on year to $24.04 billion, topping Wall Street’s revenue estimate by 9.3%, according to the company. Non-GAAP profit was $2 per share, 2.9% above consensus. The article also cites Q2 cash burn of $1.03 billion and notes the stock was about $117.50 after results.
4 min readReuters reports Bunge beat Wall Street’s Q2 profit estimates, citing strong soybean and softseed processing margins. The company raised its 2026 adjusted earnings forecast to $9.25 to $9.75 per share. Soybean processing and refining net sales were $12.07 billion, and softseed net sales were $4.09 billion. Reuters links improved demand to higher U.S. corn and soybean prices.
3 min readBunge Global SA (BG) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 epr06302026.htm EX-99.1 Document Bunge Reports Second Quarter 2026 Results St. Louis, MO - July 29, 2026 - Bunge Global SA (NYSE: BG) today reported second quarter 2026 results • Q2 GAAP diluted EPS of $3.47 vs. $2.61 in the prior year; $2.00 vs. $1.31 on an adjusted ba
6 min readBrazil’s Ministry of Labor cited Oscar Luiz Cervi over alleged forced-labor conditions on Fazenda Reata’s cotton fields. Cervi says he sells all grain and plans to sell cotton to Bunge via Viterra. Bunge says it sought more info and notes RTRS certification and audits. Fashion brands named said traceability checks found no Fazenda Reata cotton in their products.
7 min read
